Van ECK Associates Corp Invests $4.48 Million in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Van ECK Associates Corp bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 57,881 shares of the company’s stock, valued at approximately $4,475,000.

Other large investors have also recently added to or reduced their stakes in the company. First Command Advisory Services Inc. lifted its position in shares of GE HealthCare Technologies by 36,900.0% during the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after acquiring an additional 369 shares during the last quarter. Fortitude Family Office LLC purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at $29,000. Turtle Creek Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $30,000. OFI Invest Asset Management purchased a new position in GE HealthCare Technologies in the 3rd quarter worth about $26,000. Finally, Central Bank & Trust Co. acquired a new stake in GE HealthCare Technologies during the 4th quarter worth about $33,000. 82.06% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their target price for the stock from $66.00 to $88.00 in a research report on Monday, February 12th. Argus boosted their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Mizuho decreased their target price on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. Evercore ISI upped their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Finally, HSBC began coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They set a “buy” rating and a $100.00 price objective for the company. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $95.00.

GE HealthCare Technologies Trading Up 2.1 %

Shares of NASDAQ:GEHC opened at $79.47 on Monday. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. The stock has a market capitalization of $36.27 billion, a PE ratio of 23.24, a P/E/G ratio of 2.86 and a beta of 1.26. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50. The firm has a fifty day moving average price of $88.25 and a 200 day moving average price of $79.07.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The company had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter in the prior year, the company posted $0.85 EPS. The firm’s revenue was down 1.2% on a year-over-year basis. Analysts expect that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

Insiders Place Their Bets

In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,315 shares of the stock in a transaction dated Wednesday, May 1st. The shares were bought at an average cost of $76.52 per share, with a total value of $100,623.80. Following the completion of the transaction, the insider now owns 75,796 shares in the company, valued at approximately $5,799,909.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.